STONY BROOK, N.Y., March 21 /PRNewswire-FirstCall/ -- Applied DNA Sciences, Inc. , a DNA security solutions company, and Stony Brook University today announced their agreement to jointly develop a cutting edge forensic authentication system by utilizing encrypted DNA. Dr. Sanford Simon, Professor of Biochemistry, Cell Biology, and Pathology, Stony Brook University, and a director of APDN, will lead this project entitled "A Chimeric Method and System for DNA Encryption and Authentication" on behalf of the University together with Dr. Benjamin Liang, Strategic Technology Officer for Applied DNA Sciences.
Stony Brook University's Center for Advanced Technology (CAT) in Biotechnology has made a grant of $79,005.77 to APDN to partially fund the project. "We are very pleased to facilitate what we hope will be the first of many collaborative projects between the University and Applied DNA Sciences. The Center will work closely with APDN to facilitate access to both the University's and the region's life sciences infrastructure to help fuel the company's growth on Long Island," stated Dr. Clinton T. Rubin, Director, Center for Biotechnology and Professor and Chair, Department of Biomedical Engineering, Stony Brook University.
Dr. James A. Hayward, CEO of APDN, stated: "This is an important collaboration for APDN because it may help us find a more direct path to commercialization. We believe our DNA encryption and authentication system will add tremendous value to the prevention of counterfeiting and piracy. Our technology could also complement existing security solutions like holograms, inks, threads and labels. We believe our technology will greatly enhance the capabilities of product origination, identification, verification and validation of the source of components for critical manufacturing, defense, medical and other high-integrity products."
Dr. Sanford Simon, Professor of Biochemistry, Cell Biology and Pathology, Stony Brook University, said: "I am pleased to provide additional technical resources and support towards this project. Together with Dr. Liang, and APDN, we will be developing an inventory of chimeric DNA and developing authentication systems which will be incorporated into a range of different commercial and government applications."
About the Center for Biotechnology at Stony Brook University
The Center for Biotechnology at Stony Brook University is a cooperative research and development partnership between universities, private industry and New York State. It is involved in the development of commercially promising technologies in partnership with New York State companies, and the creation of strategic infrastructure that promotes the growth of the life sciences industry. Contact: Angeline Judex, Center for Biotechnology, Stony Brook University, Psychology A, 3rd Floor, Stony Brook University, Stony Brook, NY 11794-2580 Tel: 631-632-8521 Fax: 631-632-8577 http://www.biotech.sunysb.edu/
About Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (APDN) develops proprietary DNA-embedded security solutions that use plant DNA to verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion into physical plant and databases. Our common stock is registered under Section 12(g) of the Securities Exchange Act of 1934 and is listed on the Over-The-Counter Bulletin Board under the symbol "APDN". Contact: MeiLin Wan, Applied DNA Sciences, Inc., 25 Health Sciences Drive, Stony Brook, New York 11790; Tel: 631-444-6861; Fax: 631-444.8848 http://www.ADNAS.com.
The statements made by Applied DNA Sciences, Inc. may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe the Company's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA Sciences, Inc. Actual results could differ materially from those projected due to changes in interest rates, market competition, changes in the local and national economies, and various other factors detailed from time to time in Applied DNA Sciences' SEC reports and filings, including our Form 10-KSB, filed on January 12, 2006 and subsequent Form 10-QSB reports . The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
Applied DNA Sciences, Inc.CONTACT: MeiLin Wan of Applied DNA Sciences, Inc., +1-631-444-6861, fax:+1-631-444-8848, or Angeline Judex of Center for Biotechnology at StonyBrook University, +1-631-632-8521, fax: +1-631-632-8577